Platelet-driven immunothrombotic remodeling programs convert ectopic endometrium into fibrotic, immune-privileged lesions
International Immunopharmacology · 2026-10 · 186 · 117152
DOI: 10.1016/j.intimp.2026.117152 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Fateme Aghajanzadeh Goodarzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Babol University of Medical Sciences, Babol, Iran. Hauptthemen laut MEDLINE: Blood Platelets, Endometrium, Endometriosis. Die Arbeit nennt 89 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
Endometriosis is a chronic, heterogenous disorder in which cyclical hemorrhage and repetitive repair generate ectopic implants that persist, recur, and drive pain and infertility; conventional frameworks emphasizing hormonal aberration and immune failure incompletely explain lesion fibrotic maturation and spatial heterogeneity. We synthesize human, experimental, and emerging spatial-omic evidence to advance a unifying mechanistic paradigm: cyclical bleeding seeds an immunothrombotic niche in which activated platelets and fibrin scaffolds organize immune cells and stromal responders, and platelet-derived signals, including P-selectin, TGF-β and platelet-derived microparticles (PMPs), act as upstream instructors of both immune dysregulation and fibrogenic stromal reprogramming. Quantitative histology and SHG imaging demonstrate spatial platelet hotspots that co-localize with NK suppression, CD163+ macrophage polarization and aligned collagen bundles in human lesions, while PMP proteomics and functional uptake assays link vesicular cargo to myofibroblast and reparative macrophage transcriptional programs. Mechanistically, platelet TGF-β and PMP cargo downregulate NK effector receptors (for example NKG2D), reprogram macrophages toward LOX-enriched matrix-remodeling states, and bias adaptive responses toward tolerance (Treg/Th17 imbalance), creating microdomains permissive for lesion survival. These processes engage a mechanobiological feedback loop: LOX-dependent collagen crosslinking increases stiffness, which amplifies myofibroblast and immune phenotypes and further recruits platelets, consolidating fibrotic architecture. We propose a research and translational roadmap, standardized PMP pipelines, integrated scRNA/spatial cohorts, ex vivo perturbations, and early proof-of-concept trials targeting adhesion (P-selectin), PMP biology, TGF-β activation or LOX, to test causality and enable precision interventions for the "immunofibrotic" endometriosis phenotype. Reframing endometriosis as a platelet-organized immunofibrotic disorder identifies novel druggable nodes and biomarker strategies with immediate potential to change both mechanistic research and clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Babol University of Medical Sciences, Babol, Iran.
- Department of Obstetrics and Gynecology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Obstetrics and Gynecology, School of Medicine, Hormozgan University of Medical Sciences, Yasuj, Iran. Electronic address: dr.faeghehjomehpour1390@gmail.com.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Förderung
- Shahid Beheshti University of Medical Sciences
Zitieren
APA
Goodarzi, F. A., Majlesi, Z. A., Koutenaie, A., Jomehpour, F., Abtahian, A., Asadi, F., Lordejani, N. A., & Azimi, S. (2026). Platelet-driven immunothrombotic remodeling programs convert ectopic endometrium into fibrotic, immune-privileged lesions. International Immunopharmacology, 186, 117152. https://doi.org/10.1016/j.intimp.2026.117152
Vancouver
Goodarzi FA, Majlesi ZA, Koutenaie A, Jomehpour F, Abtahian A, Asadi F, et al. Platelet-driven immunothrombotic remodeling programs convert ectopic endometrium into fibrotic, immune-privileged lesions. International Immunopharmacology. 2026;186:117152. doi:10.1016/j.intimp.2026.117152
BibTeX
@article{Goodarzi2026,
author = {Goodarzi, Fateme Aghajanzadeh and Majlesi, Zahra Adib and Koutenaie, Ailinasadolahpour and Jomehpour, Faegheh and Abtahian, Ameneh and Asadi, Fatemeh and Lordejani, Neda Ardeshiri and Azimi, Samira},
title = {Platelet-driven immunothrombotic remodeling programs convert ectopic endometrium into fibrotic, immune-privileged lesions},
journal = {International Immunopharmacology},
year = {2026},
volume = {186},
pages = {117152},
doi = {10.1016/j.intimp.2026.117152}
}
EUVIMED